 | Arbutus Biopharma Corp (ABUS) Short Interest Down 31.2% in August
www.americanbankingnews.com - September 17 at 1:34 AM |
| Arbutus Biopharma Corp (ABUS) Expected to Post Quarterly Sales of $230,000.00
www.americanbankingnews.com - September 13 at 3:36 AM |
| -$0.40 EPS Expected for Arbutus Biopharma Corp (ABUS) This Quarter
www.americanbankingnews.com - September 11 at 10:16 AM |
| Arbutus Biopharma Corp (ABUS) Given Average Rating of "Buy" by Analysts
www.americanbankingnews.com - September 3 at 10:49 AM |
 | Arbutus to Participate at the 2018 B. Riley FBR Healthcare Conference
finance.yahoo.com - August 28 at 4:57 PM |
| Arbutus Biopharma Corp (ABUS) Expected to Announce Quarterly Sales of $230,000.00
www.americanbankingnews.com - August 27 at 3:37 AM |
| Brokerages Anticipate Arbutus Biopharma Corp (ABUS) to Post -$0.40 EPS
www.americanbankingnews.com - August 25 at 12:17 PM |
 | More Volatility Ahead For Arbutus Biopharma
seekingalpha.com - August 17 at 5:36 PM |
| Alnylam Receives First Ever FDA Approval For RNAi Therapeutic Treating Rare Disease Making History
seekingalpha.com - August 13 at 8:13 AM |
 | Arbutus to Present at the 2018 Wedbush PacGrow Healthcare Conference
feeds.benzinga.com - August 9 at 8:40 AM |
| Arbutus down 16% after Q2 report
seekingalpha.com - August 3 at 4:34 PM |
| Arbutus Biopharma Corp (ABUS) CEO Mark Murray on Q2 2018 Results - Earnings Call Transcript
seekingalpha.com - August 3 at 8:23 AM |
| Arbutus Reports 2018 Second Quarter Financial Results and Provides Corporate Update
finance.yahoo.com - August 2 at 5:32 PM |
| ContraVir Stock Rose on Clinical Trial Progress Report
finance.yahoo.com - July 24 at 8:38 AM |
| Arbutus Biopharma (ABUS) Shares March Higher, Can It Continue?
finance.yahoo.com - July 20 at 5:14 PM |
 | Arbutus to Report Second Quarter 2018 Financial Results
globenewswire.com - July 19 at 4:45 PM |
 | Opinion: Harry Boxer's three drug stocks to watch
www.marketwatch.com - July 19 at 4:45 PM |
| Arbutus: An Extremely Promising RNAi Innovator Hitting Its Growth Inflection
seekingalpha.com - July 19 at 8:15 AM |
| Arbutus Biopharma: Long-Term Growth Prospect Flying Too Close To The Sun
seekingalpha.com - July 18 at 4:52 PM |
| Arbutus Presents Corporate Update on Key Milestones
finance.yahoo.com - July 10 at 8:16 AM |
 | B.Riley/FBR Downgrades Arbutus Biopharma (ABUS) to Neutral
www.streetinsider.com - July 6 at 8:15 AM |
| Form 4 Arbutus Biopharma Corp For: Jun 19 Filed by: HENRIQUES RICHARD C JR
www.streetinsider.com - June 27 at 8:57 AM |
| Arbutus Biopharma: The Next Big Breakout Biotech?
seekingalpha.com - June 22 at 5:42 PM |
| Arbutus Biopharma to Present at First Annual Roivant Pipeline Day
finance.yahoo.com - June 18 at 8:50 AM |
| Arbutus appoints David C. Hastings as new Chief Financial Officer
seekingalpha.com - June 8 at 8:17 AM |
| Arbutus Biopharma (ABUS) Announces Appointment of David C. Hastings as New Chief Financial Officer
www.streetinsider.com - June 8 at 8:17 AM |
| Arbutus Biopharma's (ABUS) CEO Mark Murray on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 6 at 7:42 PM |
| Arbutus Biopharma (ABUS) Reports Q1 Loss of $0.36/Share
www.streetinsider.com - May 4 at 5:34 PM |
 | BRIEF-Arbutus Reports Q1 Loss Per Share $0.36
www.reuters.com - May 4 at 8:18 AM |
| Arbutus: 1Q Earnings Snapshot
finance.yahoo.com - May 4 at 8:18 AM |
| Arbutus Biopharma beats by $0.03, beats on revenue
seekingalpha.com - May 3 at 5:25 PM |
| Arbutus Announces Corporate Update and First Quarter 2018 Financial Results
finance.yahoo.com - May 3 at 5:25 PM |
| Merck Teams With Moderna To Take On One Of The Toughest Targets In Cancer
finance.yahoo.com - May 3 at 5:25 PM |
| Arbutus Announces Conference Call to Provide a Corporate Update and First Quarter 2018 Financial Results
finance.yahoo.com - April 30 at 5:14 PM |
| BRIEF-Arbutus And Roivant Launch Genevant Sciences With Platform To Develop Broad Range Of RNA Therapeutics ...
www.reuters.com - April 13 at 5:33 PM |
| Arbutus and Roivant Launch Genevant Sciences with Industry-Leading Platform to Develop Broad Range of RNA ...
globenewswire.com - April 13 at 5:33 PM |
| Arbutus Presents Complementary Results From Preclinical Combination Studies of HBV Therapeutic Candidates at ...
globenewswire.com - April 13 at 5:33 PM |
| Form 8-K Arbutus Biopharma Corp For: Apr 12
www.streetinsider.com - April 13 at 5:33 PM |
| Arbutus Presents Complementary Results From Preclinical Combination Studies of HBV Therapeutic Candidates at EASL 2018
finance.yahoo.com - April 12 at 5:39 PM |
| Arbutus and Roivant Launch Genevant Sciences with Industry-Leading Platform to Develop Broad Range of RNA Therapeutics for Genetic Diseases
finance.yahoo.com - April 11 at 5:32 PM |
| Arbutus to Present HBV Data at 2018 EASL Liver Meeting
finance.yahoo.com - March 29 at 8:26 AM |
| Edited Transcript of ABUS earnings conference call or presentation 15-May-07 4:00pm GMT
finance.yahoo.com - March 22 at 8:24 AM |
| Edited Transcript of ABUS earnings conference call or presentation 14-Aug-12 8:30pm GMT
finance.yahoo.com - March 22 at 8:24 AM |
| Wedbush Downgrades Arbutus Biopharma (ABUS) to Neutral Citing limited Upside in 2018 - StreetInsider.com
www.streetinsider.com - March 20 at 8:27 AM |
| Wedbush softens view on Arbutus on extended timeline for HBV candidates
seekingalpha.com - March 19 at 5:18 PM |
| Wedbush Projects Limited Upside For Arbutus Shares This Year, Moves To Sidelines
finance.yahoo.com - March 19 at 5:18 PM |
| Chardan Capital Markets Resumes Arbutus Biopharma (ABUS) at Buy - StreetInsider.com
www.streetinsider.com - March 19 at 8:22 AM |
| Arbutus Announces Corporate Update and Year-End 2017 Financial ... - GlobeNewswire (press release)
globenewswire.com - March 15 at 8:15 AM |
| 7 Stocks Moving In Wednesday's After-Hours Session | Benzinga - Benzinga
www.benzinga.com - March 15 at 8:15 AM |
| Arbutus Announces Corporate Update and Year-End 2017 Financial Results
finance.yahoo.com - March 14 at 7:08 PM |
